Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 8Thoracic 2Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 234Head and Neck Neoplasms 123Carcinoma, Non-Small-Cell Lung 78Melanoma 73Colorectal Neoplasms 43Carcinoma, Renal Cell 43Neoplasm Metastasis 35Neoplasms 33Triple Negative Breast Neoplasms 31Uterine Cervical Neoplasms 30Stomach Neoplasms 30Carcinoma, Transitional Cell 30Breast Neoplasms 30Lung Neoplasms 29Ovarian Neoplasms 28Carcinoma, Squamous Cell 24Pancreatic Neoplasms 23Carcinoma 23Esophageal Neoplasms 20Endometrial Neoplasms 19Oropharyngeal Neoplasms 18Mouth Neoplasms 18Carcinoma, Hepatocellular 18Small Cell Lung Carcinoma 17Parkinson Disease 4, Autosomal Dominant Lewy Body 16Urinary Bladder Neoplasms 13Nasopharyngeal Carcinoma 13Laryngeal Neoplasms 13Prostatic Neoplasms 12Mesothelioma 12

Interventions

pembrolizumab 1abexinostat 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy 1Drug Therapy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ureteral Neoplasms × pembrolizumab × Head & Neck × Clear all
NCT03590054 2024-03-22

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

University of California, San Francisco

Phase 1 Completed
35 enrolled
DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡